Inozyme Pharma and GACI Global Initiate Patient Burden of Disease Study to Improve the Understanding of the Severity and Impact of Disease in Patients with ENPP1 Deficiency and ABCC6 Deficiency by Seini Moimoi | May 14, 2020 | Portfolio News
Aptinyx Reports First Quarter 2020 Financial Results and Highlights by Seini Moimoi | May 14, 2020 | Portfolio News
89bio Reports First Quarter 2020 Financial Results and Provides Corporate Update by Seini Moimoi | May 13, 2020 | Portfolio News
Neurana Pharmaceuticals Announces Publication of Driving Study by Seini Moimoi | May 12, 2020 | Portfolio News
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock by Seini Moimoi | May 12, 2020 | Portfolio News
